Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data.
about
Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrierDeletion of T cells bearing the V beta8.1 T-cell receptor following mouse mammary tumor virus 7 integration confers resistance to murine cerebral malaria.T-cell-dependent immunity and thrombocytopenia in rats infected with Plasmodium chabaudi.Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in ZambiaDistinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malariaAge-related susceptibility to severe malaria associated with galectin-2 in highland PapuansRapid deletion of antigen-specific CD4+ T cells following infection represents a strategy of immune evasion and persistence for Anaplasma marginale.Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions.A surprising role for uric acid: the inflammatory malaria response.Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malariaStimulation of nitric oxide production in macrophages by Babesia bovis.DNA and a CpG oligonucleotide derived from Babesia bovis are mitogenic for bovine B cells.Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alphaChitinase 3-like 1 is induced by Plasmodium falciparum malaria and predicts outcome of cerebral malaria and severe malarial anaemia in a case-control study of African childrenThiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.Reduction of experimental cerebral malaria and its related proinflammatory responses by the novel liposome-based β-methasone nanodrug.Increased levels of soluble Fas ligand in serum in Plasmodium falciparum malaria.Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.Association of a determinant on mouse chromosome 18 with experimental severe Plasmodium berghei malaria.Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican children.Study on association between genetic polymorphisms of haem oxygenase-1, tumour necrosis factor, cadmium exposure and malaria pathogenicity and severity.Central nervous system in cerebral malaria: 'Innocent bystander' or active participant in the induction of immunopathology?A synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice.Up-regulation of Th1-type responses in mucosal leishmaniasis patientsA study of the TNF/LTA/LTB locus and susceptibility to severe malaria in highland papuan children and adults.Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum.Effects of concomitant Schistosoma haematobium infection on the serum cytokine levels elicited by acute Plasmodium falciparum malaria infection in Malian children.Kainic Acid-induced neurotoxicity: targeting glial responses and glia-derived cytokines.S1P is associated with protection in human and experimental cerebral malariaIron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis.Host-parasite interaction and morbidity in malaria endemic areas.Disruption of plasmepsin-4 and merozoites surface protein-7 genes in Plasmodium berghei induces combined virulence-attenuated phenotype.Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge.Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology.Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.Impairment of functional capillary density but not oxygen delivery in the hamster window chamber during severe experimental malaria.Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria.Malaria mimicry with tumor necrosis factor. Contrasts between species of murine malaria and Plasmodium falciparum.High Dietary Folate in Mice Alters Immune Response and Reduces Survival after Malarial Infection.Malaria--a neglected disease?
P2860
Q27322655-4190BFBF-7F1F-43CA-A8ED-97E4D1437619Q28587942-F9C1505D-3B06-4D51-9452-48557C793DAFQ33374203-89027419-8CBE-45E3-8564-6298CF29A8D3Q33393958-DF1834DF-2E2B-4035-8C77-B3B4949F32D7Q33426367-12EBA5B5-FA62-4DCB-B0CE-4F51416A7109Q33586454-710D1401-DCC5-4D71-B052-557BC7DF6306Q33626336-5D181591-0372-492D-8B0B-CFC3148AA01AQ33649697-0F7FD8D6-0B98-44A9-AAA7-9B1E9160C5BEQ33684119-9482E8C4-B879-47D9-9677-2F7B0C89EE9AQ33760891-A3D0C606-BB11-40DB-B6CE-204F70B31B19Q33761095-A8CE47C1-9190-4FE4-B19E-7E715125D056Q33767857-7E7076A9-0ACF-44A4-A759-FA9A9BD25CE4Q33771960-BBC06816-598B-4AB1-AC59-B2A20FBBD508Q33965057-F63885F1-C08D-42F5-A845-A7DEEF95DF77Q33976177-F0C3AA27-9859-4D88-99A7-0F8F5DE474D7Q34003170-59B69622-38BF-4A14-9DA7-A4D551EA7815Q34004507-8478D427-081E-4D2F-86C8-9A01422FA9B9Q34058044-E0AF2465-678D-42FB-9189-04B0777760ABQ34116823-5B215F04-6570-4E93-B568-EE2EC2597DAFQ34142179-BA751E50-95F4-4E6E-BCCA-2EA9295FB307Q34173994-21079036-A8E9-4F36-96B2-B6F56952F0F5Q34192908-2ED2F717-EA7C-4F77-B37F-1AE8B10CF502Q34218680-77246D39-30B9-4A55-B45E-46B8D2AC1E42Q34259236-06F24DC0-0ED1-4413-B60C-4B3FED3A888DQ34297619-378CD5C2-92CB-4F7E-A0EA-46975A07FF5DQ34301265-35279DD3-9BAC-4CB9-A6CE-5A10B84FABD3Q35073818-DB208C09-FD3F-4C8A-B9A6-17D5BC31E8B3Q35092168-3B18B030-239C-475C-A969-A990A3244B72Q35136728-FD34630E-2389-454E-90F6-A93CC9EBCB26Q35175642-24DD5702-BD92-4FC6-8E9D-8E725B03B3BEQ35211697-5415E9C1-1256-44D6-A67A-F3C95A890DA8Q35551353-FFF73128-E5B6-4968-B08E-18221D325556Q35605333-4F223F88-2808-4C6F-A016-59B165699416Q35682162-BE39FBA9-7171-4268-AB6B-1220C7D2C54BQ35745551-3DF3DBE8-4EA5-4FF3-A64B-A67B99CB2E81Q35750152-1A6E8AD3-4E67-473E-8B4B-F8217BE65080Q35782432-7782A3B8-EF84-44E3-A0D4-CE609CA8E25AQ35831427-8ADC4EA2-BC9B-4CA0-AF5E-99CE890E08D9Q35850162-C0DC9C50-19D2-47F3-A2A2-343674ADDDB9Q36127074-B0B237B2-3716-428A-A69F-43B60EFBBBE8
P2860
Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data.
description
1989 nî lūn-bûn
@nan
1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Tumor-necrosis factor and othe ...... xperimental and clinical data.
@ast
Tumor-necrosis factor and othe ...... xperimental and clinical data.
@en
type
label
Tumor-necrosis factor and othe ...... xperimental and clinical data.
@ast
Tumor-necrosis factor and othe ...... xperimental and clinical data.
@en
prefLabel
Tumor-necrosis factor and othe ...... xperimental and clinical data.
@ast
Tumor-necrosis factor and othe ...... xperimental and clinical data.
@en
P2093
P2860
P1476
Tumor-necrosis factor and othe ...... xperimental and clinical data.
@en
P2093
P2860
P356
10.1111/J.1600-065X.1989.TB00552.X
P577
1989-12-01T00:00:00Z